EP2429297A4 - Procédé d'administration de quantités posologiques minimales de particules d'une association de fumarate de formotérol-budésonide par inhalation - Google Patents
Procédé d'administration de quantités posologiques minimales de particules d'une association de fumarate de formotérol-budésonide par inhalationInfo
- Publication number
- EP2429297A4 EP2429297A4 EP10780911.3A EP10780911A EP2429297A4 EP 2429297 A4 EP2429297 A4 EP 2429297A4 EP 10780911 A EP10780911 A EP 10780911A EP 2429297 A4 EP2429297 A4 EP 2429297A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- inhalation
- formoterol fumarate
- budesonide
- particles
- combination particles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21637109P | 2009-05-15 | 2009-05-15 | |
PCT/US2010/001436 WO2010138158A1 (fr) | 2009-05-15 | 2010-05-14 | Procédé d'administration de quantités posologiques minimales de particules d'une association de fumarate de formotérol-budésonide par inhalation |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2429297A1 EP2429297A1 (fr) | 2012-03-21 |
EP2429297A4 true EP2429297A4 (fr) | 2013-12-25 |
Family
ID=43222995
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP10780911.3A Withdrawn EP2429297A4 (fr) | 2009-05-15 | 2010-05-14 | Procédé d'administration de quantités posologiques minimales de particules d'une association de fumarate de formotérol-budésonide par inhalation |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP2429297A4 (fr) |
WO (1) | WO2010138158A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018071435A1 (fr) * | 2016-10-11 | 2018-04-19 | Microdose Therapeutx, Inc. | Inhalateur et ses procédés d'utilisation |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007011989A2 (fr) * | 2005-07-15 | 2007-01-25 | Map Pharmaceuticals, Inc. | Multiples principes actifs pharmaceutiques combines dans des particules d'inhalation discretes et leurs formulations |
WO2007009164A1 (fr) * | 2005-07-15 | 2007-01-25 | Eiffel Technologies Limited | Procede de formation de particules |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6406745B1 (en) * | 1999-06-07 | 2002-06-18 | Nanosphere, Inc. | Methods for coating particles and particles produced thereby |
US20060257324A1 (en) * | 2000-05-22 | 2006-11-16 | Chiesi Farmaceutici S.P.A. | Pharmaceutical solution formulations for pressurised metered dose inhalers |
-
2010
- 2010-05-14 EP EP10780911.3A patent/EP2429297A4/fr not_active Withdrawn
- 2010-05-14 WO PCT/US2010/001436 patent/WO2010138158A1/fr active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007011989A2 (fr) * | 2005-07-15 | 2007-01-25 | Map Pharmaceuticals, Inc. | Multiples principes actifs pharmaceutiques combines dans des particules d'inhalation discretes et leurs formulations |
WO2007009164A1 (fr) * | 2005-07-15 | 2007-01-25 | Eiffel Technologies Limited | Procede de formation de particules |
Non-Patent Citations (1)
Title |
---|
See also references of WO2010138158A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP2429297A1 (fr) | 2012-03-21 |
WO2010138158A1 (fr) | 2010-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2010010468A (es) | Particula de suministro. | |
MX2016008226A (es) | Metodos para el cuidado oral prebiotico usando un sacarido. | |
MX2013008850A (es) | Composiciones y metodos para tratar enfermedades cardiovasculares. | |
MX2014002087A (es) | Formulaciones piretroides. | |
IL219876A (en) | Antibodies against human 1h-7b or its fragment, preparations containing them and their use in the preparation of drugs | |
MY161595A (en) | Oral care compositions | |
WO2010084480A3 (fr) | Particules de distribution | |
WO2010079466A3 (fr) | Particules de distribution | |
PH12014501158A1 (en) | Composition comprising a shelf-life stability component | |
TN2011000416A1 (en) | Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient | |
WO2012024620A3 (fr) | Inhibiteurs de l'autotaxine et leurs utilisations | |
WO2012112321A3 (fr) | Compositions dentaires comprenant un mélange de monomère d'isocyanurate et de monomère de tricyclodécane | |
EP2646019A4 (fr) | Préparation et utilisation du (+)-1-(3,4-dichlorophényl)-3-azabicyclo- [3.1.0]hexane dans le traitement des pathologies affectées par les neurotransmetteurs de type monoamine | |
UA98839C2 (en) | N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors | |
GB2511993A (en) | Prebiotic formulations and methods of use | |
EP2475358A4 (fr) | Composition noyau anionique en matiere d'administration d'agents therapeutiques, et procedes de fabrication et d'utilisation associes | |
TN2011000536A1 (en) | A novel formulation of naproxen | |
WO2014028941A3 (fr) | Composition adipeuse, systèmes et procédés | |
EP2370068A4 (fr) | Procédés et compositions pour la délivrance de médicaments aux poumons | |
NZ702930A (en) | Racecadotril liquid compositions | |
MX2014004694A (es) | Composiciones. | |
MX336225B (es) | Composiciones que comprenden sulfato de salbutamol. | |
MX2013002601A (es) | Composiciones de goma de mascar que proporcionan perfiles de liberacion de sabor. | |
MX2013012967A (es) | Composicion de miel con l-alanil-l-glutamina. | |
MX342306B (es) | Composicion de chocolate aireada. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20111012 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME RS |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: COOK, ROBERT O. Inventor name: DE GUZMAN, VERONICA, S. |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20131127 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 9/72 20060101AFI20131121BHEP Ipc: A61K 31/58 20060101ALI20131121BHEP Ipc: A61K 31/167 20060101ALI20131121BHEP |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: MAP PHARMACEUTICALS INC |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20161201 |